Breast Biopsy Devices - Global Strategic Business Report

The global market for Breast Biopsy Devices was valued at US$1.8 Billion in 2024 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Breast Biopsy Device Market - Key Trends and Drivers Summarized

Breast cancer remains a leading cause of cancer-related deaths among women worldwide. This underscores the critical need for effective screening tools that can accurately detect cancer early, improving patient outcomes and reducing mortality rates. Breast biopsy devices play a crucial role in diagnosing breast cancer and abnormalities, as accurate early detection can significantly reduce mortality rates. Market growth for these devices is driven by a rising incidence of breast cancer and advancements in imaging technology, such as mammography, MRI, and ultrasound. Image-guided biopsies now allow precise targeting of suspicious lesions, enhancing diagnostic accuracy while minimizing repeat procedures and patient discomfort. National screening programs have also increased awareness, leading to higher demand for biopsies.

Key trends include technological innovations such as vacuum-assisted biopsies and automated biopsy guns, which offer greater accuracy, less invasiveness, and improved patient comfort compared to traditional methods. Minimally invasive methods, such as vacuum-assisted needle biopsies, are gaining popularity due to reduced discomfort and scarring. Automated disposable biopsy devices help prevent infection, reduce operator fatigue, and increase efficiency. Integration with advanced imaging and AI technologies refines the biopsy process by identifying the best sites for tissue extraction, reducing unnecessary biopsies, and enhancing diagnostic efficiency.

Precision medicine is also shaping the biopsy market, as biomarker-driven insights from biopsy samples enable personalized treatment plans. AI helps tailor therapies based on individual genetic profiles and disease characteristics, providing clinicians with comprehensive analyses and actionable insights. This shift towards personalized and precision medicine is enhancing the biopsy's value beyond diagnosis, leading to more effective and individualized cancer interventions.

Report Scope

The report analyzes the Breast Biopsy Devices market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Forceps, Biopsy Needles, Other Products); End-Use (Diagnostic Clinics, Hospitals, Other End-Uses).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Biopsy Guidance Systems segment, which is expected to reach US$983.4 Million by 2030 with a CAGR of a 6%. The Needle Based Biopsy Guns segment is also set to grow at 6.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $476.2 Million in 2024, and China, forecasted to grow at an impressive 9.2% CAGR to reach $551.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Breast Biopsy Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Breast Biopsy Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Breast Biopsy Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Aurora Imaging Technology, Inc., Becton, Dickinson and Company, Becton, Dickinson and Company, Hologic, Inc., Mammotome and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 23 companies featured in this Breast Biopsy Devices market report include:

• Aurora Imaging Technology, Inc.
• Becton, Dickinson and Company
• Becton, Dickinson and Company
• Hologic, Inc.
• Mammotome
• Planmed Oy